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Purpose: This study was undertaken to determine the natural history of physical function in older men limited by
intermittent claudication.
Methods: Forty-three men limited by intermittent claudication (mean age, 69  7 years) were recruited and followed up
for 18 months. At baseline the patients reported a history of intermittent claudication for 6.1  6.1 years, and were able
to walk for 1.9  1.6 blocks before experiencing claudication pain. Measurements during the 18-month study included
ankle-brachial index (ABI), calf blood flow, 6-minute walk performance, monitored and self-reported physical activity,
self-reported stability while walking, and summary performance score of physical function determined from a 4-m walk
test, a chair stand test, and a tandem stand test.
Results: Pain-free walking distance during the 6-minute walk test decreased by 22% (P < .05) from baseline (185 96 m)
to follow-up (144  93 m), and the total 6-minute walk distance decreased by 9% (P < .05), from 368  106 m to 334
 90 m. Furthermore, monitored physical activity decreased by 31% (P < .05), from 159  151 kcal/d to 110  137
kcal/d; self-reported physical activity declined by 27% (P < .05), from 1.5  1.0 units to 1.1  0.8 units; tandem stance
time declined by 14% (P < .05), from 9.46  1.83 seconds to 8.12  2.10 seconds; summary performance score of
physical function decreased by 12% (P < .05), from 6.8  2.4 units to 6.0  2.4 units; and the percentage of patients
reporting ambulatory unsteadiness and stumbling increased from 28% to 43% (P < .05). Calf blood flow measured at rest
declined by 18% (P < .05), from 3.72  1.81 (mL/100 mL1/min1) to 3.04  1.43 mL/100 mL1/min1, whereas
ABI did not change (P > .05).
Conclusion. Older men limited by intermittent claudication experienced decline in ambulatory function, physical activity,
physical function, stability, and calf blood flow over 18 months of follow-up, despite no change in ABI. (J Vasc Surg
2004;40:73-8.)Peripheral arterial disease (PAD) is a leading cause of
morbidity due to ambulatory limitations associated with
intermittent claudication.1 Intermittent claudication af-
fects 5% of the US population older than 55 years,2 thereby
limiting daily physical activities3 and negatively affecting
quality of life4 in many older adults. Although 25% of
patients with PAD with intermittent claudication will ex-
perience deterioration in symptoms over 5 years,5,6 the
remaining 75% will either stabilize or improve. Thus, from
the standpoint of symptoms, in many patients with PAD
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doi:10.1016/j.jvs.2004.02.010with intermittent claudication the clinical course is rela-
tively stable,5-11 with little change over 18 months in
claudication distances measured with a standardized tread-
mill test.12 However, the extremely sedentary lifestyle of
patients with intermittent claudication3 places them at high
risk for subsequent decline in mobility and physical func-
tion13 even if symptoms remain unchanged.
The long-term functional consequences of chronic in-
termittent claudication have received little attention, and
may have a significant effect on the physical independence
of patients with PAD. A recent study found that disability in
ambulatory function will likely develop during 40 months
of follow-up in older women with PAD compared with
women without PAD.14 However, no information is avail-
able regarding the long-term change in functional perfor-
mance in older men with PAD. Given that older men with
PAD have a higher level of physical activity than older
women with PAD,15 it remains unclear whether men with
chronic intermittent claudication experience similar deteri-
oration in ambulation and functional performance.
The purpose of this study was to determine the natural




Screening. Forty-three consecutive older men limited
by intermittent claudication were followed up for 1873
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land Claude D. Pepper Older Americans Independence
Center. The screening procedures and measurements ob-
tained in this pilot study were similar to those used in the
intervention and intervention development studies of the
Pepper Center.12 The patients were recruited from the
Vascular Clinic at the Baltimore location of the Maryland
Veterans Affairs Health Care System. All patients were
classified as having Fontaine stage II PAD,16 defined by the
following inclusion criteria: Rose questionnaire positive for
intermittent claudication17 and ankle-brachial index (ABI)
at rest less than 0.90.2 Further entry criteria required pa-
tients to be 60 years of age or older, be limited by intermit-
tent claudication, live independently at home, and not be
taking pentoxifylline or cilostazol for treatment of intermit-
tent claudication. The institutional review boards at the
University of Maryland and the Maryland Veterans Affairs
Health Care System at Baltimore approved the procedures
used in this study. Written informed consent was obtained
from each subject before investigation.
Baseline clinical characteristics. The study group
consisted of 43 men (63% white, 37% African American),
with average age of 69 7 years, who reported intermittent
claudication symptoms present for 6.1 6.1 years and who
could walk 1.9  1.6 blocks before experiencing the onset
of intermittent claudication. Furthermore, 95% of the
group had a history of cigarette smoking (44% currently
smoked, 51% formerly smoked), 63% had a history of
coronary artery disease, 37% had diabetes, 61% had hyper-
tension, 40% had hyperlipidemia, 12% had a history of
chronic obstructive pulmonary disease, and 47% reported a
history of exertional dyspnea.
Procedures. Patients were evaluated during study vis-
its at baseline and after 6 and 18 months of follow-up.
During each study visit patients completed tests in the
following order: medical history, including review of cur-
rent medications; questionnaires regarding health, physical
function, and physical activity; peripheral hemodynamic
tests; and physical function tests. At the end of the study
visit an activity monitor was placed on each patient, who
was instructed to wear it during waking hours. Patients
were scheduled to return the monitor after at least 2 days so
that the physical activity data could be recorded. Patients
were encouraged by study personnel to adopt a healthy
lifestyle, including regular exercise, healthy eating, and, if
applicable, smoking cessation. These general recommenda-
tions were provided to mimic the advice patients typically
receive during vascular clinic follow-up appointments.
Measurements
Medical history. Demographic information, cardio-
vascular risk factors, comorbid conditions, self-reported
claudication history, and a list of current medications were
obtained during a medical history interview to begin the
evaluation.
ABI. The ABI was obtained from the more severely
diseased lower extremity with Doppler ultrasound after 10minutes of supine rest, as described.18 The test-retest intra-
class reliability coefficient is R  0.96 for ABI.18
Calf blood flow. Calf blood flow was obtained under
resting, reactive hyperemic, and maximal hyperemic condi-
tions in the more severely diseased leg, with venous occlu-
sion mercury strain gauge plethysmography, as de-
scribed.19 The test-retest intraclass reliability coefficient is
R  0.86 for calf blood flow.19
Six-minute walk test. Patients performed an over
ground, 6-minute walk test, supervised by trained exercise
technicians, as described.20 Pain-free and total distance
walked during the test were recorded. The test-retest intra-
class reliability coefficient is R  0.75 for the distance to
onset of claudication pain, and R  0.94 for the total
6-minute walking distance.20
Walking Impairment Questionnaire. Self-reported
ambulatory ability was assessed with a validated question-
naire for PAD that assesses ability to walk at various speeds
and distances, and to climb stairs.21
Four-meter walk test. Pain-free ambulatory function
was assessed with a 4-m walk test in a hallway.22 Patients
performed this test twice at their usual walking pace, and
the faster of the two walks was used for analysis.22-24 The
test-retest intraclass reliability coefficient is R  0.96 for
the velocity to walk 4 m.
Chair stand test. Lower extremity strength, balance,
and endurance were assessed with a chair stand test, in
which the time to perform five sequential sit-to-stand trans-
fers from an armless 18-inch high chair was recorded.22,25
The test-retest intraclass reliability coefficient is R  0.89
for the time to complete the repeated chair rise test.
Balance measures. Patients performed a unipedal
stance for a maximum of 60 seconds with their eyes open
and both arms held loosely at their sides.26,27 In addition,
balance was assessed by measuring the time that patients
could stand in side-by-side, semi-tandem, and full-tandem
positions for a maximum of 10 seconds, as described,28,29
and by asking patients if over the last year they had often
stumbled or felt unsteady when they walked.26 A stumble
was defined as loss of balance that was restored before a fall
occurred, and unsteadiness was defined as routine or regu-
lar sense of difficulty with balance while walking.27 The
test-retest intraclass reliability coefficients for the time that
subjects could stand in the three respective positions are
R  0.99, R  0.99, and R  0.95.
Summary performance score. The summary perfor-
mance score was calculated from the performance of the
4-m walk, chair stand test, and standing balance test, as
described.22,30 The summary performance score ranges
from 0 to 12 (0, worst function; 12, best function), and is
predictive of mobility loss, nursing home placement, and
mortality among community-dwelling elderly persons.22,30
The test-retest intraclass reliability coefficient is R  0.93
for the summary performance score.
Physical activity. Physical activity level was monitored
over two consecutive weekdays with a Caltrac accelerome-
ter (Muscle Dynamics, Torrance, Calif) attached to the belt
of each subject, as described.31 The accelerometer assessed
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tions of the body into caloric expenditure during the 48-
hour monitoring period.32,33 In addition, a physical activ-
ity scale was used to assess the self-reported physical activity
level over the preceding month, as described.3,34 The ac-
celerometer measure of physical activity has a test-retest
intraclass reliability coefficient of R 0.84,34 and provides
a valid estimate of daily physical activity assessed with the
standard technique of doubly labeled water.31
Health Utilities Index. The Health Utilities Index,
ranging from 0 (worst imaginable health) to 100 (best
imaginable health), was used to assess self-reported health,
as described.35 Patients were asked to select a numeric value
on the scale that best corresponded to their current overall
health state.
Statistical analysis
One-factor (time) repeated measures analysis of vari-
ance (ANOVA) was used to compare changes in functional
and physiologic variables over the 18-month study. Statis-
tical significance was set at P  .05 for each ANOVA. Post
hoc paired t tests were used to locate pairwise mean differ-
ences between time points when a significant time main
effect was found at ANOVA. Bonferroni adjustment (P 
.017) was used for the three pairwise comparisons (baseline
vs 6 months, baseline vs 18 months, 6 months vs 18
months), to control the type I error rate at 5% within each
variable. Pearson product moment correlation coefficients
(r) were calculated to determine the association between
change in variables after exercise rehabilitation. All analyses
were performed with the SPSS-PC statistical package
(SPSS, Chicago, Ill). Measurements are presented as mean
 SD.
RESULTS
During 18 months of follow-up, five patients (12%)
who did not report angina at baseline had symptoms by the
end of the study. Furthermore, two patients (5%) had a
myocardial infarction during the study, and three patients
(7%) underwent coronary bypass. Two patients (5%) expe-
Table I. Measured physical function and physical activity l
Variable 0
Six-minute walk pain-free distance (m) 185  96
Six-minute walk distance (m) 368  106
Four-meter walk velocity (m/s) 1.12  0.36
Chair stand time (s) 16.85  6.65
Tandem stance time (s) 9.46  1.83
Unipedal stance time (s) 18.16  17.71
Summary performance score (units) 6.8  2.4
Daily physical activity (kcal/d) 159  151
Values represent mean  SD.
  Month 18 value minus month 0 value.
*Significantly different from month 0 (P  .017).
†Significantly different from month 6 (P  .017).
‡Significant change (P  .05).rienced a transient ischemic attack during the study, and
four patients (9%) who did not report exertional dyspnea at
baseline had symptoms during the 18-month follow-up. All
patients remained functionally limited by intermittent clau-
dication at the end of the study. No deaths occurred during
this relatively short follow-up period.
Laboratory measurements of physical function and
physical activity are shown in Table I. During the first 6
months of follow-up no significant changes (P .05) were
noted for any variables. However, after 18 months of
follow-up the pain-free walking distance during the
6-minute walk test decreased by 22% (P  .05), total
6-minute walk distance decreased by 9% (P  .05), moni-
tored physical activity decreased by 31% (P .05), tandem
stance time declined by 14% (P  .05), and summary
performance score decreased by 12% (P  .05). No signif-
icant changes (P  .05) were noted in 4-m walk velocity,
chair stand time, and unipedal stance time by the end of the
study. The change in monitored physical activity was cor-
related with the change in pain-free walking distance dur-
ing the 6-minute walk test (r  0.40; P  .05), change in
total 6-minute walk distance (r  0.31; P  .05), and
change in summary performance score (r 0.52; P .01).
Self-reported measurements of health, physical func-
tion, and physical activity are shown in Table II. During the
first 6 months of follow-up no significant changes (P .05)
were noted for any of the variables. However, after 18
months of follow-up self-reported physical activity declined
by 27% (P .05), and the percentage of patients reporting
ambulatory stumbling and unsteadiness increased by 15%
(P .05). No significant changes (P .05) were observed
for self-perceived health, self-reported ability to ambulate
at various distances and speeds, or stair climbing by the end
of the study.
Peripheral hemodynamic measurements obtained dur-
ing the study are displayed in Table III. During the first 6
months of follow-up no significant changes (P .05) were
noted for any variables. However, after 18 months of
follow-up calf blood flow measured at rest declined by 18%
in 43 older men limited by intermittent claudication
Follow-up (mo)
6 18
177  86 144  93*† 41  89‡
370  113 334  90*† 34  59‡
1.07  0.24 1.01  0.26 0.11  0.66
16.82  7.35 16.05  6.06 0.80  6.26
8.79  2.56 8.12  2.56* 1.34  2.57‡
18.48  18.34 18.59  18.27 0.43  18.97
6.6  2.3 6.0  2.4*† 0.8  1.25‡
127  173 110  137* 49  98‡evel
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calf blood flow obtained during post occlusive reactive
hyperemic and maximal hyperemic conditions, and for ABI
by the end of the study. The change in calf blood flow
measured at rest correlated with the change in pain-free
walking distance during the 6-minute walk test (r  0.37;
P  .05), and change in total 6-minute walk distance
(r  0.33; P  .05).
DISCUSSION
The major findings of this investigation were that older
men with intermittent claudication experience declines in
6-minute walk performance, monitored and self-reported
physical activity, physical performance, measured and self-
reported stability, and calf blood flow despite no change in
ABI over an 18-month follow-up.
This study is the first to show a decline in pain-free
walking distance during the 6-minute walk test in patients
with PAD after 18 months of usual medical care. The
shorter pain-free distance suggests that older men with
intermittent claudication have gradually diminished ability
to ambulate free of pain during activities that require more
Table II. Self-reported health, physical function, and phys
claudication
Variable 0
Self-perceived health (%) 73  24
WIQ distance score (%) 31  32
WIQ speed score (%) 33  34




Physical activity scale (units) 1.5  1.0
Values represent mean  SD.
  Month 18 value minus month 0 value.
WIQ, Walking Impairment Questionnaire.
*Significantly different from month 0 (P  .017).
†Significant change (P  .05).
‡Significantly different from month 6 (P  .017).
Table III. Peripheral hemodynamic measurements in 43 o
Variable 0
Ankle-brachial index 0.57  0.19
Calf blood flow
(mL/100 mL1/min1)
Resting 3.72  1.81
PORH 10.36  6.42
Maximal 13.07  6.73
Values represent mean  SD.
  Month 18 value minus month 0 value.
PORH, Post-occlusive reactive hyperemia.
*Significantly different from month 0 (P  .017).
†Significantly different from month 6 (P  .017).
‡Significant change (P  .05).than several minutes of continuous walking. The decline in
the pain-free walking distance over 18 months of follow-up
was related to both the decrease in monitored daily physical
activity and decrease in calf blood flow at rest. These results
indicate that patients who experienced the largest declines
in daily physical activity and calf blood flow also had the
largest decline in pain-free walking distance. Consequently,
changes in physical activity and calf blood flow are possible
explanations for the more rapid development of claudica-
tion during the 6-minute walk test.
The reduction in total distance covered during the
6-minute walk test suggests that physical endurance de-
clined during the study. The decline in the 6-minute walk
distance was related to both the decrease in monitored daily
physical activity and the decrease in calf blood flow at rest,
suggesting that changes in physical activity and calf blood
flow are possible explanations for impaired walking endur-
ance. This finding does not support a previous report from
our laboratory in which no change in 6-minute walk dis-
tance occurred in a non-exercise control group during an
18-month, randomized, controlled exercise trial.12 The
divergent findings are probably due to differences in the
ctivity level in 43 older men limited by intermittent
llow-up (mo)
6 18
75  22 73  17 0  26
27  30 28  32 3  32
29  26 26  26 7  22
36  33 35  35 2  36
35 43* 15†
.4  0.9 1.1  0.8*‡ 0.4  0.8†
men limited by intermittent claudication
low-up (mo)
6 18
.55  0.15 0.59  0.17 0.02  0.12
.57  1.79 3.04  1.43*† 0.68  1.54‡
.83  4.57 9.83  4.14 0.53  5.67
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were screened at baseline, and only those who were deemed
eligible to participate in an exercise program were random-
ized into either the exercise or control groups. In contrast,
the current study followed consecutive patients seen in the
vascular clinic, regardless of whether they were candidates
for an exercise program. As a result, patients in the current
study were more functionally limited and less physically
active at baseline than were patients in the control group in
our previous study.12
The lack of change in perceived claudication symp-
toms, as measured by the Walking Impairment Question-
naire (WIQ), supports previous investigations that report
stabilization in symptoms over time.5,6,10,11
However, that pain-free distance during the 6-minute
walk test declined during this study suggests that symptoms
did not remain stable over the 18-month follow-up. One
explanation for the lack of change in WIQ measures of
self-reported ability to walk various distances and speeds,
and to climb stairs is that daily physical activity declined by
30% during the study. Consequently, not enough walking
may have been performed throughout the course of a day
to elicit intermittent claudication, thereby limiting the abil-
ity of patients to accurately report changes in symptoms.
Another possible explanation is that the WIQ is a subjective
instrument to assess claudication pain, and therefore may
be less sensitive to detect change in claudication pain than is
the more objective measure of pain-free distance during the
6-minute walk test. Regardless of the reasons for the lack of
change in WIQ measures, the results of this investigation
suggest that changes in claudication pain may be undetec-
ted unless they are objectively measured on a periodic basis.
In addition to progression in ambulatory dysfunction
during this trial, patients experienced functional decline in
stability and physical function. The number of men report-
ing stumbling and unsteadiness during ambulation in-
creased, and the time to hold a tandem stance decreased
over the 18-month follow-up. These finding support pre-
vious work from our laboratory that demonstrated impair-
ment in these measurements in patients with PAD com-
pared with control subjects without PAD.26 The
implication of the current finding is that older men with
intermittent claudication experience gradual loss of stability
while they stand and walk, increasing the risk for falls.
Furthermore, a decline in physical function, as measured by
the summary performance score, occurred in the patients
with PAD. This supports a previous study in which the
summary performance score declined in older women with
PAD.14 The decline in the summary performance score was
related to the decrease in monitored physical activity, indi-
cating that those patients who experienced the largest
decline in the summary performance score also had the
largest decline in daily physical activity. Consequently, a
change in physical activity is a possible explanation for the
decline in physical function. The decline in the summary
performance score in the current group of older men with
intermittent claudication suggests that they are at increasedrisk for subsequent mobility loss, nursing home placement,
and mortality.22,30
A decrease in calf blood flow at rest was observed in the
patients in this investigation, whereas no change occurred
in calf blood flow measured under reactive hyperemic and
maximal hyperemic conditions. The 18% decline in calf
blood flow at rest is similar in magnitude to the 12%36 and
13%37 declines reported in control subjects in previous
investigations. However, the change in calf blood flow was
not statistically significant in either of these studies, because
of small sample size of only eight patients in both investi-
gations.36,37 The change in calf blood flow occurred de-
spite no change in ABI, suggesting that calf blood flow may
be a more sensitive measure to detect vascular changes than
ABI is. The lack of change in ABI is supported by previous
studies,38,39 and indicates that PAD, defined by ABI, did
not worsen during this study.
The primary limitation of this study is that an age-
matched and gender-matched control group without PAD
was not included in the research design. Thus it is difficult
to determine whether the declines in functional measures
are primarily due to aging as opposed to progression of
underlying disease or progression in physical inactivity. The
lack of change in ABI during this study suggests that
progression of disease is an unlikely explanation for the
observed declines in physical function. Although the reduc-
tion in daily physical activity and calf blood flow during the
study are more plausible explanations for the decline in
physical function, the notion that aging mediates changes
in physical activity, calf blood flow, and physical function
cannot be ruled out.
In conclusion, older men limited by intermittent clau-
dication experienced decline in ambulatory function, phys-
ical activity, physical function, stability, and calf blood flow
during 18 months of follow-up, despite no change in ABI.
Thus older men with intermittent claudication may gradu-
ally lose physical independence even in the absence of a
decrease in ABI.
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